Pancrease-V Powder (Canada)This page contains information on Pancrease-V Powder for veterinary use.
The information provided typically includes the following:
- Pancrease-V Powder Indications
- Warnings and cautions for Pancrease-V Powder
- Direction and dosage information for Pancrease-V Powder
Pancrease-V PowderThis treatment applies to the following species:
Veterinary Use Only
Each 2.8 g (1 tsp.) of Pancrelipase USP 100% w/w contains:
Lipase (67,200 USP Units), Protease (280,000 USP Units), and Amylase (280,000 USP Units). Each 2.8 g (1 tsp.) of Pancrelipase USP 100% w/w digests (in vitro): 236 g Fat, 280 g Protein, and 280 g Starch.
WarningsAvoid inhaling the product. Exercise caution during handling & measuring of product if you have a known allergy to proteins of porcine origin. Keep out of reach of children.
Pancrease-V Powder Indications
For enzyme replacement therapy in conditions due to exocrine pancreatic insufficiency in dogs and cats.
Dosage and AdministrationAdminister orally. Mix Pancrease-V Powder with pet’s food 20 minutes before feeding.
Dogs: 2.8 - 4.2 g (1 - 1 1/2 tsp.) with each meal.
Cats: 1.4 - 2.1 g (1/2 - 3/4 tsp.) with each meal.
Dosage is dependent upon degree of pancreatic insufficiency. Consult your veterinarian for frequency of meals and adjustment of dosage.
CAUTIONS: Discontinue use if symptoms of sensitivity occur.
StorageStore in a tightly closed container in a dry place at temperature not exceeding 25°C.
Bioniche Animal Health Canada Inc., P.O. Box 1570, Belleville, Ontario, Canada K8N 5J2
Net 114 g
NAC No.: 12150246
Distributed by VETOQUINOL N.-A. INC.
2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
|Every effort has been made to ensure the accuracy of the Pancrease-V Powder information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-04-21